Share JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced that it will report first quarter fiscal year 2026 financial results on Wednesday, November 5, 2025, after the closing of the market. The company will host a conference call and live webcast to review the results on Thursday, November 6, 2025, at 10:00 a.m. Eastern Time. Kimball Electronics Q1 Fiscal 2026 earnings conference call and webcast to be held on Thursday, November 6, at 10:00 a.m. Eastern Time. Kimball Elec ...

Eli Lilly plans to invest more than $1 billion in India over the next few years to build new contract manufacturing capabilities in the South Asian nation, underscoring the US drugmaker’s push to bolster its global supply network https://t.co/apxPq1fUdj ...

Summary of Fabrinet (FN) FY Conference Call - May 15, 2025 Company Overview - **Company**: Fabrinet (FN) - **Industry**: Optical manufacturing and contract manufacturing - **Key Management**: Seamus Grady (CEO), Shava Swerha (CFO) Key Insights and Arguments Customer Behavior and Macro Environment - No observed changes in customer ordering patterns or behaviors, indicating stability in demand despite macroeconomic concerns [3][4] - Majority of products are for infrastructure applications, which are less sensitive to consumer sentiment [4] Revenue Composition and Market Expansion - Approximately 75% of revenue is derived from optical manufacturing, with significant contributions from telecom and datacom sectors [6] - Engagement with AWS and other customers is prompting Fabrinet to expand its capabilities beyond just optical manufacturing [5][6] Contract Manufacturing Strategy - Fabrinet remains focused on contract manufacturing and is not entering the product business, ensuring no competition with existing customers [8][24] - The company is expanding into advanced packaging and system assembly to enhance service offerings [9][10] Datacom Business and Customer Relationships - NVIDIA is the largest customer, with a long-standing relationship that began with Mellanox; significant volumes of transceivers are produced for NVIDIA's products [14][15] - Anticipation of ramping up production for the 1.6T transceivers, with readiness to support new product launches [19][20] Competitive Landscape - The market is growing rapidly, and while competition is increasing, Fabrinet believes there is enough business for all players [30][31] - The company emphasizes its specialized capabilities and low-cost structure as competitive advantages [32] Technology Transitions - Transitioning from 800G to 1.6T is expected to be less impactful on pricing than historically, due to cost-saving measures and increased in-house production [39][41] - Concerns about losing market share in 800G are addressed by the introduction of new versions that will coexist with existing products [46] CPO and Future Technologies - Fabrinet is involved in multiple co-packaged optics (CPO) projects, indicating a strategic position in the evolving optical communication landscape [49][50] - The company sees CPO as a long-term opportunity but acknowledges that it is still in early development stages [50] Financial Outlook and Growth Drivers - Anticipated modest headwinds in Q4 due to simultaneous new product ramps, but expected to resolve quickly as these products gain traction [55][56] - Significant revenue potential from the new Amazon business, with the possibility of it becoming a major customer [65][72] Telecom Market Dynamics - The telecom business is segmented into baseline growth, 400ZR products, and new system wins, all of which are currently experiencing growth [74][78] - The company plans to disclose DCI as a separate category in future reports to provide clearer insights into revenue streams [77] Additional Important Points - The decision to issue warrants to Amazon aligns interests and provides revenue visibility, indicating a strong partnership [65][66] - Fabrinet's manufacturing capabilities are complex and not easily replicable, providing a competitive edge in the face of global tariff concerns [35][36] This summary encapsulates the key points discussed during the conference call, highlighting Fabrinet's strategic positioning, market dynamics, and future growth opportunities.

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $2,810,000, representing a 121% increase year over year compared to $1,270,000 in Q1 2024 [5][21] - Gross margins normalized to 42.4%, compared to 37% in Q4 2024 and 43.6% in Q3 2024 [5][22] - EBITDA loss narrowed to negative $540,000 from negative $840,000 in the same period last year [6][23] - Net loss for Q1 2025 was $710,000, down from a net loss of $850,000 in Q1 2024 [23] Business Line Data and Key Metrics Changes - Contract manufacturing revenue increased by 58% year over year, driven by demand from existing customers and new partnerships [5] - Consumer branded products revenue surged by 189% year over year, significantly boosted by the addition of Silly George [5] - The company expects continued growth in both contract manufacturing and consumer products, with a robust pipeline for 2025 [8][11] Market Data and Key Metrics Changes - The company is seeing increased interest in U.S.-made gels due to potential tariff impacts, which may enhance competitiveness against imported products [19] - There is a growing market for hydrogel applications, particularly in laser hair removal, with significant interest from major companies [42] Company Strategy and Development Direction - The company plans to expand its product lines, including new offerings for MetaGel and Cancoderm, and is transitioning Silly George into a broader beauty brand [12][13] - The partnership with Stata is progressing well, with plans for additional product launches in 2025 and 2026 [14] - The company is strategically managing cash and R&D to ensure high ROI while pursuing growth opportunities [14] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about achieving $13,000,000 in revenue and cash flow positivity in 2025 despite external challenges [20] - The company is monitoring tariff situations closely and is prepared to adjust manufacturing strategies if necessary [16][19] - Management expressed confidence in the growth potential of their products and the overall market, despite uncertainties in the broader economic environment [60] Other Important Information - The company has a cash balance of approximately $1,190,000 as of March 31, 2025 [23] - The company has 7,654,537 shares of common stock outstanding as of May 13, 2025 [23] Q&A Session Summary Question: How much revenue was expected from AbbVie, and does the delay affect guidance? - Management indicated that not much revenue was baked in from AbbVie, so the delay should not significantly impact the $13,000,000 projection [25][26] Question: Can you provide details on the product launch with Stata? - The first product is Histosol, a digestive enzyme, with plans for additional digestive enzymes in the future [30] Question: Is there a seasonal improvement expected for Silly George? - Management expects seasonal growth, especially with new product launches planned for Q3 and Q4 [61][62] Question: Will transitioning manufacturing to Texas impact other business lines? - The company has built a new clean room with enough capacity to accommodate potential shifts in manufacturing [35][36] Question: Will the company survive on current cash reserves until EBITDA positive? - Management believes they can manage with current cash reserves until reaching EBITDA positivity [66]